{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:16:17Z","timestamp":1782962177954,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jneuroim.2021.577493","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T22:10:16Z","timestamp":1611267016000},"page":"577493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Cerebrospinal fluid CXCL10 is associated with the presence of low level CSF HIV during suppressive antiretroviral therapy"],"prefix":"10.1016","volume":"353","author":[{"given":"Albert M.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suprateek","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin","family":"Vaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwakemi","family":"Okwuegbuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"McClernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Cherner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Cookson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Crescini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Gisslen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Letendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2021.577493_bb0005","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s00415-006-0481-8","article-title":"CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration","volume":"254","author":"Abdulle","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/infdis\/jiw505","article-title":"Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy","volume":"215","author":"Anderson","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0015","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0020","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/650538","article-title":"Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy","volume":"50","author":"Canestri","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/13854040490501448","article-title":"Initial validation of a screening battery for the detection of HIV-associated cognitive impairment","volume":"18","author":"Carey","year":"2004","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2009.09.002","article-title":"Cerebrospinal fluid levels of chemokines in HIV infected patients with and without opportunistic infection of the central nervous system","volume":"287","author":"Christo","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jneuroim.2005.07.002","article-title":"Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection","volume":"168","author":"Cinque","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0040","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1158\/1055-9965.EPI-16-0964","article-title":"Excess mortality among HIV-infected individuals with cancer in the United States","volume":"26","author":"Coghill","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0045","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1212\/WNL.50.5.1388","article-title":"Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier","volume":"50","author":"Correale","year":"1998","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0050","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/13803395.2010.535504","article-title":"Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change","volume":"33","author":"Cysique","year":"2011","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0055","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1097\/QAD.0000000000000400","article-title":"Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation","volume":"28","author":"Dahl","year":"2014","journal-title":"Aids."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V85.1.1.bloodjournal8511","article-title":"CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy","volume":"85","author":"Falini","year":"1995","journal-title":"Blood."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12668","article-title":"Serum sCD30: a promising biomarker for predicting the risk of bacterial infection after kidney transplantation","volume":"19","author":"Fernandez-Ruiz","year":"2017","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cytogfr.2012.01.001","article-title":"Interferon-alpha (IFNalpha) neurotoxicity","volume":"23","author":"Fritz-French","year":"2012","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0075","article-title":"Revised Comprehensive norms for an expanded Halstead- Reitan Battery: Demographically adjusted neuropsycho- logical norms for African American and Caucasian adults scoring program Lutz, FL.: Psychological Assessment","author":"Heaton","year":"2004","journal-title":"Resources"},{"key":"10.1016\/j.jneuroim.2021.577493_bb0080","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006856","article-title":"Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30","volume":"14","author":"Hogan","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0090","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"Hutter","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088591","article-title":"Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients","volume":"9","author":"Jessen Krut","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2021.577493_bb0100","series-title":"HIV-1 Replication in the CNS Is Associated With Increased Neurocognitive Impairment. Poster 440 Conference on Retroviruses and Opportunistic Infections February 2015, Seattle Washington","author":"Joseph","year":"2015"},{"key":"10.1016\/j.jneuroim.2021.577493_bb0105","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1128\/JVI.00674-16","article-title":"HIV DNA is frequently present within pathologic tissues evaluated at autopsy from combined antiretroviral therapy-treated patients with undetectable viral loads","volume":"90","author":"Lamers","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0110","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/(SICI)1097-4547(19960915)45:6<758::AID-JNR12>3.0.CO;2-S","article-title":"Transcriptional regulation of chemokine gene expression in astrocytes","volume":"45","author":"Majumder","year":"1996","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75233-z","article-title":"Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury","volume":"10","author":"Minta","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0120","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/13803395.2011.559157","article-title":"Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version","volume":"33","author":"Norman","year":"2011","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006112","article-title":"Early antiretroviral therapy is associated with lower HIV DNA molecular diversity and lower inflammation in cerebrospinal fluid but does not prevent the establishment of compartmentalized HIV DNA populations","volume":"13","author":"Oliveira","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0130","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/QAD.0b013e328355e6b2","article-title":"Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load","volume":"26","author":"Peluso","year":"2012","journal-title":"Aids."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S2055-6640(20)30006-6","article-title":"Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1","volume":"6","author":"Peluso","year":"2020","journal-title":"J. Virus Erad."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0140","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0145","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.neuroimage.2017.03.021","article-title":"Cerebrospinal and interstitial fluid transport via the glymphatic pathway modeled by optimal mass transport","volume":"152","author":"Ratner","year":"2017","journal-title":"NeuroImage."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070201","article-title":"Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir\/ritonavir: an exploratory study","volume":"8","author":"Santos","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2021.577493_bb0155","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1172\/JCI127413","article-title":"Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance","volume":"129","author":"Spudich","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2021.577493_bb0160","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/JVI.01844-08","article-title":"Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections","volume":"83","author":"Stacey","year":"2009","journal-title":"J. Virol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572821000205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572821000205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:38:15Z","timestamp":1759048695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572821000205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":32,"alternative-id":["S0165572821000205"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577493","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid CXCL10 is associated with the presence of low level CSF HIV during suppressive antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577493"}}